HspB8 prevents aberrant phase transitions of FUS by chaperoning its folded RNA binding domain

  1. Edgar E Boczek
  2. Julius Fürsch
  3. Marie Laura Niedermeier
  4. Louise Jawerth
  5. Marcus Jahnel
  6. Martine Ruer-Gruß
  7. Kai-Michael Kammer
  8. Peter Heid
  9. Laura Mediani
  10. Jie Wang
  11. Xiao Yan
  12. Andrej Pozniakovski
  13. Ina Poser
  14. Daniel Mateju
  15. Lars Hubatsch
  16. Serena Carra
  17. Dr. Simon Alberti
  18. Anthony A Hyman
  19. Florian Stengel  Is a corresponding author
  1. Max Planck Institute of Molecular Cell Biology and Genetics, Germany
  2. University of Konstanz, Germany
  3. Max Planck Institute for the Physics of Complex Systems, Germany
  4. Biotec, TU Dresden, Germany
  5. University of Modena and Reggio Emilia, Italy

Abstract

Aberrant liquid-to-solid phase transitions of biomolecular condensates have been linked to various neurodegenerative diseases. However, the underlying molecular interactions that drive aging remain enigmatic. Here, we develop quantitative time-resolved crosslinking mass spectrometry to monitor protein interactions and dynamics inside condensates formed by the protein fused in sarcoma (FUS). We identify misfolding of the RNA recognition motif (RRM) of FUS as a key driver of condensate ageing. We demonstrate that the small heat shock protein HspB8 partitions into FUS condensates via its intrinsically disordered domain and prevents condensate hardening via condensate-specific interactions that are mediated by its α-crystallin domain (αCD). These αCD-mediated interactions are altered in a disease-associated mutant of HspB8, which abrogates the ability of HspB8 to prevent condensate hardening. We propose that stabilizing aggregation-prone folded RNA-binding domains inside condensates by molecular chaperones may be a general mechanism to prevent aberrant phase transitions.

Data availability

All data generated or analysed during this study are included in this published article (and its supplementary information files). The MS data (raw files, xQuest, xTract and in-house quantitation output files) have been deposited to the ProteomeXchange Consortium via the PRIDE (60) partner repository with the dataset identifier PXD021114 (Username: reviewer33076@ebi.ac.uk; Password: 5atfkbP8) and PXD021115 (Username: reviewer54149@ebi.ac.uk; Password: UZW7Gnr5).

The following data sets were generated

Article and author information

Author details

  1. Edgar E Boczek

    Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany
    Competing interests
    Edgar E Boczek, is currently an employee of Dewpoint Therapeutics..
  2. Julius Fürsch

    Department of Biology, University of Konstanz, Konstanz, Germany
    Competing interests
    No competing interests declared.
  3. Marie Laura Niedermeier

    Department of Biology, University of Konstanz, Konstanz, Germany
    Competing interests
    No competing interests declared.
  4. Louise Jawerth

    Max Planck Institute for the Physics of Complex Systems, Dresden, Germany
    Competing interests
    No competing interests declared.
  5. Marcus Jahnel

    Biophysics, Biotec, TU Dresden, Dresden, Germany
    Competing interests
    No competing interests declared.
  6. Martine Ruer-Gruß

    Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany
    Competing interests
    No competing interests declared.
  7. Kai-Michael Kammer

    Department of Biology, University of Konstanz, Konstanz, Germany
    Competing interests
    No competing interests declared.
  8. Peter Heid

    Department of Biology, University of Konstanz, Konstanz, Germany
    Competing interests
    No competing interests declared.
  9. Laura Mediani

    University of Modena and Reggio Emilia, Modena, Italy
    Competing interests
    No competing interests declared.
  10. Jie Wang

    Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany
    Competing interests
    No competing interests declared.
  11. Xiao Yan

    Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany
    Competing interests
    No competing interests declared.
  12. Andrej Pozniakovski

    Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany
    Competing interests
    No competing interests declared.
  13. Ina Poser

    Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany
    Competing interests
    Ina Poser, is currently an employee of Dewpoint Therapeutics.
  14. Daniel Mateju

    Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany
    Competing interests
    No competing interests declared.
  15. Lars Hubatsch

    Max Planck Institute for the Physics of Complex Systems, Dresden, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1934-7437
  16. Serena Carra

    University of Modena and Reggio Emilia, Modena, Italy
    Competing interests
    No competing interests declared.
  17. Dr. Simon Alberti

    Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany
    Competing interests
    Dr. Simon Alberti, is a shareholder, consultant and member of the scientific advisory board for Dewpoint Therapeutics..
  18. Anthony A Hyman

    Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany
    Competing interests
    Anthony A Hyman, is cofounder, shareholder, consultant and member of the scientific advisory board for Dewpoint Therapeutics..
  19. Florian Stengel

    Department of Biology, University of Konstanz, Konstanz, Germany
    For correspondence
    Florian.Stengel@uni-konstanz.de
    Competing interests
    Florian Stengel, is a consultant and member of the scientific advisory board for Dewpoint Therapeutics..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1447-4509

Funding

Deutsche Forschungsgemeinschaft (STE 2517/1-1)

  • Florian Stengel

Konstanz Research School Chemical Biology (Chemicals and small Equipment Purchase)

  • Florian Stengel

Deutsche Forschungsgemeinschaft (Cluster of Excellence Physics of Life"")

  • Dr. Simon Alberti

Deutsche Forschungsgemeinschaft (Cluster of Excellence Physics of Life"")

  • Anthony A Hyman

EU Joint Programme – Neurodegenerative Disease Research (Neurodegenerative Disease Research (JPND))

  • Serena Carra

EU Joint Programme – Neurodegenerative Disease Research (Neurodegenerative Disease Research (JPND))

  • Dr. Simon Alberti

AriSLA Foundation (Granulopathy and MLOpathy)

  • Serena Carra

MAECI (Dissolve_ALS)

  • Serena Carra

MIUR (E91I18001480001)

  • Serena Carra

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2021, Boczek et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,240
    views
  • 576
    downloads
  • 54
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Edgar E Boczek
  2. Julius Fürsch
  3. Marie Laura Niedermeier
  4. Louise Jawerth
  5. Marcus Jahnel
  6. Martine Ruer-Gruß
  7. Kai-Michael Kammer
  8. Peter Heid
  9. Laura Mediani
  10. Jie Wang
  11. Xiao Yan
  12. Andrej Pozniakovski
  13. Ina Poser
  14. Daniel Mateju
  15. Lars Hubatsch
  16. Serena Carra
  17. Dr. Simon Alberti
  18. Anthony A Hyman
  19. Florian Stengel
(2021)
HspB8 prevents aberrant phase transitions of FUS by chaperoning its folded RNA binding domain
eLife 10:e69377.
https://doi.org/10.7554/eLife.69377

Share this article

https://doi.org/10.7554/eLife.69377

Further reading

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Flavia A Zanetti, Ignacio Fernandez ... Laura Ruth Delgui
    Research Article

    Birnaviruses are a group of double-stranded RNA (dsRNA) viruses infecting birds, fish, and insects. Early endosomes (EE) constitute the platform for viral replication. Here, we study the mechanism of birnaviral targeting of EE membranes. Using the Infectious Bursal Disease Virus (IBDV) as a model, we validate that the viral protein 3 (VP3) binds to phosphatidylinositol-3-phosphate (PI3P) present in EE membranes. We identify the domain of VP3 involved in PI3P-binding, named P2 and localized in the core of VP3, and establish the critical role of the arginine at position 200 (R200), conserved among all known birnaviruses. Mutating R200 abolishes viral replication. Moreover, we propose a two-stage modular mechanism for VP3 association with EE. Firstly, the carboxy-terminal region of VP3 adsorbs on the membrane, and then the VP3 core reinforces the membrane engagement by specifically binding PI3P through its P2 domain, additionally promoting PI3P accumulation.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Stephanie M Stuteley, Ghader Bashiri
    Insight

    In the bacterium M. smegmatis, an enzyme called MftG allows the cofactor mycofactocin to transfer electrons released during ethanol metabolism to the electron transport chain.